Literature DB >> 34772811

Vaccine-elicited CD4 T cells prevent the deletion of antiviral B cells in chronic infection.

Kerstin Narr1, Yusuf I Ertuna1, Benedict Fallet1, Karen Cornille1, Mirela Dimitrova1, Anna-Friederike Marx1, Katrin Martin1, Tiago Abreu Mota1, Marco Künzli2, David Schreiner2, Tobias M Brunner3,4, Mario Kreutzfeldt5,6, Ingrid Wagner6, Florian Geier7, Lukas Bestmann8, Max Löhning3,4, Doron Merkler5,6, Carolyn G King2, Daniel D Pinschewer9.   

Abstract

Chronic viral infections subvert protective B cell immunity. An early type I interferon (IFN-I)-driven bias to short-lived plasmablast differentiation leads to clonal deletion, so-called "decimation," of antiviral memory B cells. Therefore, prophylactic countermeasures against decimation remain an unmet need. We show that vaccination-induced CD4 T cells prevented the decimation of naïve and memory B cells in chronically lymphocytic choriomeningitis virus (LCMV)-infected mice. Although these B cell responses were largely T independent when IFN-I was blocked, preexisting T help assured their sustainability under conditions of IFN-I-driven inflammation by instructing a germinal center B cell transcriptional program. Prevention of decimation depended on T cell-intrinsic Bcl6 and Tfh progeny formation. Antigen presentation by B cells, interactions with antigen-specific T helper cells, and costimulation by CD40 and ICOS were also required. Importantly, B cell-mediated virus control averted Th1-driven immunopathology in LCMV-challenged animals with preexisting CD4 T cell immunity. Our findings show that vaccination-induced Tfh cells represent a cornerstone of effective B cell immunity to chronic virus challenge, pointing the way toward more effective B cell-based vaccination against persistent viral diseases.

Entities:  

Keywords:  B cell decimation; T cell help; T follicular helper cells; chronic viral infection; interferon

Mesh:

Substances:

Year:  2021        PMID: 34772811      PMCID: PMC8694065          DOI: 10.1073/pnas.2108157118

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  87 in total

1.  Clonal B cells in patients with hepatitis C virus-associated mixed cryoglobulinemia contain an expanded anergic CD21low B-cell subset.

Authors:  Edgar D Charles; Claudia Brunetti; Svetlana Marukian; Kimberly D Ritola; Andrew H Talal; Kristen Marks; Ira M Jacobson; Charles M Rice; Lynn B Dustin
Journal:  Blood       Date:  2011-03-18       Impact factor: 22.113

2.  Interferons direct Th2 cell reprogramming to generate a stable GATA-3(+)T-bet(+) cell subset with combined Th2 and Th1 cell functions.

Authors:  Ahmed N Hegazy; Michael Peine; Caroline Helmstetter; Isabel Panse; Anja Fröhlich; Andreas Bergthaler; Lukas Flatz; Daniel D Pinschewer; Andreas Radbruch; Max Löhning
Journal:  Immunity       Date:  2010-01-14       Impact factor: 31.745

3.  Limited humoral immunity in hepatitis C virus infection.

Authors:  M Chen; M Sällberg; A Sönnerborg; O Weiland; L Mattsson; L Jin; A Birkett; D Peterson; D R Milich
Journal:  Gastroenterology       Date:  1999-01       Impact factor: 22.682

Review 4.  Are booster immunisations needed for lifelong hepatitis B immunity? European Consensus Group on Hepatitis B Immunity.

Authors: 
Journal:  Lancet       Date:  2000-02-12       Impact factor: 79.321

5.  Transcriptional profiling of mouse B cell terminal differentiation defines a signature for antibody-secreting plasma cells.

Authors:  Wei Shi; Yang Liao; Simon N Willis; Nadine Taubenheim; Michael Inouye; David M Tarlinton; Gordon K Smyth; Philip D Hodgkin; Stephen L Nutt; Lynn M Corcoran
Journal:  Nat Immunol       Date:  2015-04-20       Impact factor: 25.606

6.  Antibody-mediated protection against SHIV challenge includes systemic clearance of distal virus.

Authors:  Jinyan Liu; Khader Ghneim; Devin Sok; William J Bosche; Yuan Li; Elizabeth Chipriano; Brian Berkemeier; Kelli Oswald; Erica Borducchi; Crystal Cabral; Lauren Peter; Amanda Brinkman; Mayuri Shetty; Jessica Jimenez; Jade Mondesir; Benjamin Lee; Patricia Giglio; Abishek Chandrashekar; Peter Abbink; Arnaud Colantonio; Courtney Gittens; Chantelle Baker; Wendeline Wagner; Mark G Lewis; Wenjun Li; Rafick-Pierre Sekaly; Jeffrey D Lifson; Dennis R Burton; Dan H Barouch
Journal:  Science       Date:  2016-08-18       Impact factor: 47.728

7.  Complex Antigens Drive Permissive Clonal Selection in Germinal Centers.

Authors:  Masayuki Kuraoka; Aaron G Schmidt; Takuya Nojima; Feng Feng; Akiko Watanabe; Daisuke Kitamura; Stephen C Harrison; Thomas B Kepler; Garnett Kelsoe
Journal:  Immunity       Date:  2016-03-03       Impact factor: 31.745

Review 8.  In search of a new paradigm for protective immunity to TB.

Authors:  Cláudio Nunes-Alves; Matthew G Booty; Stephen M Carpenter; Pushpa Jayaraman; Alissa C Rothchild; Samuel M Behar
Journal:  Nat Rev Microbiol       Date:  2014-03-03       Impact factor: 60.633

9.  Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals.

Authors:  Susan Moir; Jason Ho; Angela Malaspina; Wei Wang; Angela C DiPoto; Marie A O'Shea; Gregg Roby; Shyam Kottilil; James Arthos; Michael A Proschan; Tae-Wook Chun; Anthony S Fauci
Journal:  J Exp Med       Date:  2008-07-14       Impact factor: 14.307

10.  LEF-1 and TCF-1 orchestrate T(FH) differentiation by regulating differentiation circuits upstream of the transcriptional repressor Bcl6.

Authors:  Youn Soo Choi; Jodi A Gullicksrud; Shaojun Xing; Zhouhao Zeng; Qiang Shan; Fengyin Li; Paul E Love; Weiqun Peng; Hai-Hui Xue; Shane Crotty
Journal:  Nat Immunol       Date:  2015-07-27       Impact factor: 25.606

View more
  1 in total

1.  Adoptive B cell therapy for chronic viral infection.

Authors:  Young Rock Chung; Tanushree Dangi; Nicole Palacio; Sarah Sanchez; Pablo Penaloza-MacMaster
Journal:  Front Immunol       Date:  2022-07-26       Impact factor: 8.786

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.